SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-24-230253
Filing Date
2024-10-01
Accepted
2024-10-01 16:46:06
Documents
7

Document Format Files

Seq Description Document Type Size
1 S-3 d832065ds3.htm S-3 141762
2 EX-5.1 d832065dex51.htm EX-5.1 10345
3 EX-23.2 d832065dex232.htm EX-23.2 1671
4 EX-FILING FEES d832065dexfilingfees.htm EX-FILING FEES 14898
5 GRAPHIC g832065g00n03.jpg GRAPHIC 41276
6 GRAPHIC g832065g44k39.jpg GRAPHIC 2982
7 GRAPHIC g832065g85q98.jpg GRAPHIC 2334
  Complete submission text file 0001193125-24-230253.txt   234211
Mailing Address 200 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 200 SIDNEY STREET CAMBRIDGE MA 02139 617 945 9626
Seres Therapeutics, Inc. (Filer) CIK: 0001609809 (see all company filings)

IRS No.: 274326290 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-282450 | Film No.: 241343984
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)